Balance Sheet Data

4D Molecular Therapeutics, Inc. (FDMT)

$22.67

-0.40 (-1.73%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 23.8591.7649.65276.73247.78289.97450.07698.561,084.241,682.87
Total Cash (%)
Account Receivables 0.321.120.981.490.052.173.365.228.1012.57
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 0.460.951.741.792.383.695.738.9013.8221.44
Accounts Payable (%)
Capital Expenditure -0.57-0.41-3.20-1-9.11-6.52-10.13-15.72-24.40-37.87
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.